2
May
Active cell transport of oligonucleotide drugs
Oligonucleotide drug therapeutics are a potential drug class for wide range of diseases. With just 9 approved products they already generated more than 2 billion
MORE →-
-
22
Marbaseclick and Tebubio Join Forces to Revolutionize Nucleic Acid Bioconjugation and Labeling
Munich March.22.2024 This partnership represents a significant milestone in advancing the field of nucleic acid bioconjugation and labeling, providing researchers with unprecedented access to cutting-edge
MORE → -
21
Marbaseclick GmbH attends Analytica
We’re thrilled to announce our participation in Analytica 2024, one of the leading trade fairs for laboratory technology, analysis, and biotechnology. This exciting event brings
MORE → -
8
MarOur CEO Dr. Frischmuth shares our newest innovations at RNA Leader conference.
Discover the future of molecular innovation with baseclick. Leading the way in antisense oligonucleotide and mRNA development using Nobel price-winning click chemistry. Visiting our CEO
MORE → -
22
FebJoin us for Bio CEO & Investor Conference in New York
Excited to announce that our CEO Dr. Thomas Frischmuth is attending the Bio CEO & Investor Conference, where we will be showcasing our pioneering innovations
MORE →